Skip to content
healthcare.dev

Dyrenium

NDC 59212-002, Triamterene, capsule, from Advanz Pharma (US) Corp..

Product NDC
59212-002
Status
Listed
Labeler
Advanz Pharma (US) Corp.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA013174
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59212-002 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TRIAMTERENE50 mg/1

Pharmacologic classes

Decreased Renal K+ Excretion [PE]; Increased Diuresis [PE]; Potassium-sparing Diuretic [EPC]

Package NDCNDC-11Package
59212-002-0159212000201100 CAPSULE in 1 BOTTLE (59212-002-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ebb177c0-d45d-4443-a85a-e76bd9931a42

Use it

Look up 59212-002 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59212-002 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59212-002. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.